Early prenatal diagnosis of causative homozygous variants in ASCC1 in a fetus with cystic hygroma and additional homozygous variants of unknown significance associated with a neurological phenotype not visible in early gestation: Dual diagnosis or not?
Journal
Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
revised:
23
12
2023
received:
27
07
2023
accepted:
26
12
2023
medline:
18
3
2024
pubmed:
12
2
2024
entrez:
11
2
2024
Statut:
ppublish
Résumé
A consanguineous couple was referred at 10 weeks of gestation (WG) for prenatal genetic investigations due to isolated cystic hygroma. Prenatal trio exome sequencing identified causative homozygous truncating variants in ASCC1 previously implicated in spinal muscular atrophy with congenital bone fractures. Prenatal manifestations in ASCC1 can usually include hydramnios, fetal hypo-/akinesia, arthrogryposis, contractures and limb deformities, hydrops fetalis and cystic hygroma. An additional truncating variant was identified in CSPP1 associated with Joubert syndrome. Presentations in CSPP1 include cerebellar and brainstem malformations with vermis hypoplasia and molar tooth sign, difficult to visualize in early gestation. A second pregnancy was marked by the recurrence of isolated increased nuchal translucency at 10 + 2 WG. Sanger prenatal diagnosis targeted on ASCC1 and CSPP1 variants showed the presence of the homozygous familial ASCC1 variant. In this case, prenatal exome sequencing analysis is subject to a partial ASCC1 phenotype and an undetectable CSPP1 phenotype at 10 weeks of gestation. As CSPP1 contribution is unclear or speculative to a potentially later in pregnancy or postnatal phenotype, it is mentioned as a variant of uncertain significance. The detection of pathogenic or likely pathogenic variants involved in severe disorders but without phenotype-genotype correlation because the pregnancy is in the early stages or due to prenatally undetectable phenotypes, will encourage the clinical community to define future practices in molecular prenatal reporting.
Substances chimiques
ASCC1 protein, human
0
Carrier Proteins
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
352-356Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Tran Mau-Them F, Delanne J, Denommé-Pichon A-S, et al. Prenatal diagnosis by trio exome sequencing in fetuses with ultrasound anomalies: a powerful diagnostic tool. Front Genet. 2023;14(23 mars 2023):1099995. https://doi.org/10.3389/fgene.2023.1099995
Knierim E, Hirata H, Wolf NI, et al. Mutations in subunits of the activating signal cointegrator 1 complex are associated with prenatal spinal muscular atrophy and congenital bone fractures. Am J Hum Genet. 2016;98(3):473-489. https://doi.org/10.1016/j.ajhg.2016.01.006
Oliveira J, Martins M, Pinto Leite R, Sousa M, Santos R. The new neuromuscular disease related with defects in the ASC-1 complex: report of a second case confirms ASCC1 involvement. Clin Genet. 2017;92(4):434-439. https://doi.org/10.1111/cge.12997
Böhm J, Malfatti E, Oates E, et al. Novel ASCC1 mutations causing prenatal-onset muscle weakness with arthrogryposis and congenital bone fractures. J Med Genet. 2019;56(9):617-621. https://doi.org/10.1136/jmedgenet-2018-105390
Guadagnolo D, Mastromoro G, Hashemian NK, et al. Fetal first-trimester cystic hygroma as the prenatal presenting feature of ASCC1-related spinal muscular atrophy with bone fractures 2. J Obstet Gynaecol Can JOGC. 2023;45(8):558-559. https://doi.org/10.1016/j.jogc.2023.05.004
Mace P, Mancini J, Gorincour G, Quarello E. Accuracy of qualitative and quantitative cranial ultrasonographic markers in first-trimester screening for open spina bifida and other posterior brain defects: a systematic review and meta-analysis. BJOG An Int J Obstetrics Gynaecol. 2021;128(2):354-365. https://doi.org/10.1111/1471-0528.16530